Hepatitis B vaccines. On the threshold.

American journal of clinical pathology ·Vol. 70 ·No. 1 Suppl ·1978-07-00 ·Pages 159-69

Purcell RH, Gerin JL

Abstract

Experimental hepatitis B vaccines have recently been developed and are undergoing preliminary evaluation. These vaccines are unique in that they are prepared from viral antigen purified from the plasmas of human chronic carriers because hepatitis B virus has not been cultivated in vitro. They appear to be safe and antigenic, but care must be exercised in their evaluation because of the potential risks inherent in all vaccines.

MeSH Terms

Animals Antigen-Antibody Reactions Antigens Blood Proteins Cost-Benefit Analysis Culture Techniques Drug Contamination Hepatitis B/epidemiology,immunology,microbiology,transmission Hepatitis B Antigens/classification Hepatitis B Core Antigens/isolation & purification Hepatitis B virus/immunology Herpesviridae/immunology Humans Liver Proteins Risk Viral Vaccines/adverse effects,isolation & purification

Chemicals

Antigens Blood Proteins Hepatitis B Antigens Hepatitis B Core Antigens Proteins Viral Vaccines

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Purcell R H

Gerin J L

Article Info

Journal

American journal of clinical pathology

Abbr.

Am J Clin Pathol

ISSN

0002-9173

Published

1978-07-00

Pages

159-69

Language

English

Region

England

NLM ID

0370470

Subset

External Links

PubMed source View journal details

Analysis Services

Hepatitis B vaccines. On the threshold.

Contact

WeChat Official Account